Influenza is a contagious respiratory illness that the influenza virus causes leading to the infection of nose, throat, and sometimes the lungs. It can result into mild to severe illness and sometimes can lead to death. Three types of influenza virus affect people that includes: type A, type B, and type C. Influenza is spread via infectious respiratory secretions that is caused by the formation of aerosol due to direct contact with an infected person. The influenza can cause seasonal epidemics along with high levels of mortality and morbidity. A number of factors are responsible for the overall growth of the global influenza diagnostics market. Increasing prevalence of influenza and related chronic disease along with the rising geriatric population base is one of the major factors for the growth of the market. However, increasing price of diagnostic kits and reagents hinder the growth of the market. Moreover, there is a huge opportunity of the global influenza diagnostic market in the near future due to enormous funding and investment, and support provided by the government for influenza diagnostics. For an instance, San Diego-based Cue Health was awarded up to million by the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority. The funding was provided for enhancing the development and regulatory validation of over-the-counter and professional-use influenza and multiplex respiratory pathogen diagnostic cartridges for health monitoring system of the company.
To Request a Sample of our Report on Influenza Diagnostics Market : https://www.omrglobal.com/request-sample/influenza-diagnostics-market
The influenza diagnostics market can be segmented on the basis of, type, test type and end users. Based on the type, the influenza diagnostics market is bifurcated as type A flu, type B flu and type C flu. On the basis of test type, the market is diversified as rapid influenza diagnostic test, serological assay, nucleic acid sequence-based amplification test, loop-mediated isothermal amplification-based assay, simple amplification-based assay and other tests. Based on the end users, the influenza diagnostics market is sub-divided as hospitals, and research labs.
(Get 15% Discount on Buying this Report)
Browse for Full Report Description at : https://www.omrglobal.com/industry-reports/influenza-diagnostics-market
GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY TYPE OF FLU
- TYPE A FLU
- TYPE B FLU
- TYPE C FLU
GLOBAL INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE
- RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT)
- SEROLOGICAL ASSAY
- NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) TESTS
- LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAYS (LAMP)
- SIMPLE AMPLIFICATION-BASED ASSAYS (SAMBA)
GLOBAL INFLUENZA DIAGNOSTICS BY END USERS
- HOSPITALS & DIAGNOSTIC CENTERS
- RESEARCH LABS
- KEY COMPANY ANALYSIS
- KEY STRATEGY ANALYSIS
- UNITED STATES
REST OF THE WORLD
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/influenza-diagnostics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
Company Name: Orion Market Research